- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
AstraZeneca Pharma India Limited — Updates, 28-07-2026: General Updates
28-07-2026 | 01:22 pm
28-07-2026 | 01:22 pm
AstraZeneca Pharma India gets approval to import and market Trastuzumab Deruxtecan (Enhertu®) for expanded use in HER2-positive Stage II/III breast cancer. This development boosts the drug's market scope in India.
No comments yet. Be the first to comment!